Normal values of the 6-min walk distance (6MWD) for children have not been well demonstrated. This limits the interpretation of the 6MWD in children.
METHODS:
A cross-sectional prospective study was designed. A total of 949 (467 males, 482 females) healthy children were recruited randomly from 7 Turkish secondary schools in Ankara. The 6-min walk tests were conducted according to the American Thoracic Society guidelines.
RESULTS:
The mean 6MWD decreased between the ages of 12 and 14 y for both boys and girls, and then gradually increased until 17 y of age. In the best fitting and most efficient linear, quadratic, and categorical regression models, the age of the subjects, heart rate after the test, and physical activity level of the subjects were significantly related to the 6MWD. Nevertheless, these variables explained < 20% of the variance in the 6MWD.
CONCLUSIONS:
The 6MWD does not increase in a straight linear fashion from the age of 12 until adulthood. Correlation of the 6MWD with anthropometric features is very weak, so in evaluating the 6MWD, the standard curves should be used.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. American Thorax Society statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med, 2002; 166(1):111–117.
2.
SolwayS, BrooksD, LacasseY, ThomasS. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest, 2001; 119(1):256–270.
3.
GuyattGH, TownsendM, KellerJ, SingerJ, NogradiS. Measuring functional status in chronic lung disease: conclusions from a randomized control trial. Respir Med, 1991; 85Suppl B:17–21; discussion 33-37.
4.
MaiyaS, HislopAA, FlynnY, HaworthSG. Response to bosentan in children with pulmonary hypertension. Heart, 2006; 92(5):664–670.
5.
MoallaW, GauthierR, MaingourdY, AhmaidiS. Six-minute walking test to assess exercise tolerance and cardiorespiratory responses during training program in children with congenital heart disease. Int J Sports Med, 2005; 26(9):756–762.
6.
GulmansVA, van VeldhovenNH, de MeerK, HeldersPJ. The six-minute walking test in children with cystic fibrosis: reliability and validity. Pediatr Pulmonol, 1996; 22(2):85–89.
7.
HassanJ, van der NetJ, HeldersPJ, PrakkenBJ, TakkenT. Six-minute walk test in children with chronic conditions. Br J Sports Med, 2010; 44(4):270–274.
8.
PaapE, van der NetJ, HeldersPJ, TakkenT. Physiologic response of the six-minute walk test in children with juvenile idiopathic arthritis. Arthritis Rheum, 2005; 53(3):351–356.
9.
MorinderG, MattssonE, SollanderC, MarcusC, LarssonUE. Six-minute walk test in obese children and adolescents: reproducibility and validity. Physiother Res Int, 2009; 14(2):91–104.
10.
MaherCA, WilliamsMT, OldsTS. The six-minute walk test for children with cerebral palsy. Int J Rehabil Res, 2008; 31(2):185–188.
11.
TakkenT, EngelbertR, van BergenM, GroothoffJ, NautaJ, van HoeckK, et al. Six-minute walking test in children with ESRD: discrimination validity and construct validity. Pediatr Nephrol, 2009; 24(11):2217–2223.
12.
YimlamaiD, FreibergerDA, GouldA, ZhouJ, BoyerD. Pretransplant six-minute walk test predicts peri- and post-operative outcomes after pediatric lung transplantation. Pediatr Transplant, 2013; 17(1):34–40.
13.
GeigerR, StrasakA, TremlB, GasserK, KleinsasserA, FischerV, et al. Six-minute walk test in children and adolescents. J Pediatr, 2007; 150(4):395–399, 399e391–392.
14.
LammersAE, HislopAA, FlynnY, HaworthSG. The 6-minute walk test: normal values for children of 4-11 years of age. Arch Dis Child, 2008; 93(6):464–468.
15.
LiAM, YinJ, AuJT, SoHK, TsangT, WongE, et al. Standard reference for the six-minute-walk test in healthy children aged 7 to 16 years. Am J Respir Crit Care Med, 2007; 176(2):174–180.
16.
PriesnitzCV, RodriguesGH, Stumpf CdaS, ViapianaG, CabralCP, SteinRT, et al. Reference values for the 6-min walk test in healthy children aged 6-12 years. Pediatr Pulmonol, 2009; 44(12):1174–1179.
17.
Ben SaadH, PrefautC, MissaouiR, MohamedIH, TabkaZ, HayotM. Reference equation for 6-min walk distance in healthy North African children 6-16 years old. Pediatr Pulmonol, 2009; 44(4):316–324.
18.
TonklangN, RoymaneeS, SopontammarakS. Developing standard reference data for Thai children from a six-minute walk test. J Med Assoc Thai, 2011; 94(4):470–475.
19.
KlepperSE, MuirN. Reference values on the 6-minute walk test for children living in the United States. Pediatr Phys Ther, 2011; 23(1):32–40.
20.
UlrichS, HildenbrandFF, TrederU, FischlerM, KeuschS, SpeichR, FasnachtM. Reference values for the 6-minute walk test in healthy children and adolescents in Switzerland. BMC Pulm Med, 2013; 13:49.
LiAM, YinJ, YuCC, TsangT, SoHK, WongE, et al. The six-minute walk test in healthy children: reliability and validity. Eur Respir J, 2005; 25(6):1057–1060.
23.
MidgleyPC, WardhaughB, MacfarlaneC, MagowanR, KelnarCJ. Blood pressure in children aged 4-8 years: comparison of Omron HEM 711 and sphygmomanometer blood pressure measurements. Arch Dis Child, 2009; 94(12):955–958.
24.
BorgGA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc, 1982; 14(5):377–381.
25.
HommerdingPX, DonadioMV, PaimTF, MarosticaPJ. The Borg scale is accurate in children and adolescents older than 9 years with cystic fibrosis. Respir Care, 2010; 55(6):729–733.
26.
GarberCE, BlissmerB, DeschenesMR, FranklinBA, LamonteMJ, LeeIM, et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc, 2011; 43(7):1334–1359.
27.
ButtJ, WeinbergRS, BreckonJD, ClaytorRP. Adolescent physical activity participation and motivational determinants across gender, age, and race. J Phys Act Health, 2011; 8(8):1074–1083.
28.
PohH, EastwoodPR, CecinsNM, HoKT, JenkinsSC. Six-minute walk distance in healthy Singaporean adults cannot be predicted using reference equations derived from Caucasian populations. Respirology, 2006; 11(2):211–216.
29.
RoulG, GermainP, BareissP. Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure?. Am Heart J, 1998; 136(3):449–457.
30.
OgdenCL, CarrollMD, CurtinLR, McDowellMA, TabakCJ, FlegalKM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA, 2006; 295(13):1549–1555.
31.
BrancaF, NikogosianH, LobsteinT (eds). Current prevalence and trends of overweight and obesity. In: The challenge of obesity in the WHO European Region and the strategies for response. Copenhagen, Denmark: World Health Organization; 2007:5.
32.
GibbonsWJ, FruchterN, SloanS, LevyRD. Reference values for a multiple repetition 6-minute walk test in healthy adults older than 20 years. J Cardiopulm Rehabil, 2001; 21(2):87–93.
